341 related articles for article (PubMed ID: 29755451)
1. Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model.
Sajda T; Sinha AA
Front Immunol; 2018; 9():692. PubMed ID: 29755451
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
Egu DT; Walter E; Spindler V; Waschke J
Br J Dermatol; 2017 Dec; 177(6):1612-1618. PubMed ID: 28600798
[TBL] [Abstract][Full Text] [Related]
3. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
[TBL] [Abstract][Full Text] [Related]
4. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
5. The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the "Super Compensation Hypothesis".
Sinha AA; Sajda T
Front Med (Lausanne); 2018; 5():218. PubMed ID: 30155465
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
[TBL] [Abstract][Full Text] [Related]
7. Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.
Spindler V; Vielmuth F; Schmidt E; Rubenstein DS; Waschke J
J Immunol; 2010 Dec; 185(11):6831-8. PubMed ID: 21037102
[TBL] [Abstract][Full Text] [Related]
8. What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? A systematic review.
Brescacin A; Baig Z; Bhinder J; Lin S; Brar L; Cirillo N
J Cell Physiol; 2022 Jul; 237(7):2825-2837. PubMed ID: 35616233
[TBL] [Abstract][Full Text] [Related]
9. The pathogenic role of autoantibodies in pemphigus vulgaris.
Pan M; Liu X; Zheng J
Clin Exp Dermatol; 2011 Oct; 36(7):703-7. PubMed ID: 21906124
[TBL] [Abstract][Full Text] [Related]
10. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization.
Berkowitz P; Hu P; Liu Z; Diaz LA; Enghild JJ; Chua MP; Rubenstein DS
J Biol Chem; 2005 Jun; 280(25):23778-84. PubMed ID: 15840580
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
12. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A
J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
[TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide.
Lucchese A; Sinha AA
Clin Exp Dermatol; 2016 Aug; 41(6):585-90. PubMed ID: 26936204
[TBL] [Abstract][Full Text] [Related]
14. Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus.
Sajda T; Hazelton J; Patel M; Seiffert-Sinha K; Steinman L; Robinson W; Haab BB; Sinha AA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1859-64. PubMed ID: 26831096
[TBL] [Abstract][Full Text] [Related]
15. Immune response in pemphigus and beyond: progresses and emerging concepts.
Di Zenzo G; Amber KT; Sayar BS; Müller EJ; Borradori L
Semin Immunopathol; 2016 Jan; 38(1):57-74. PubMed ID: 26597100
[TBL] [Abstract][Full Text] [Related]
16. Pemphigus, a pathomechanism of acantholysis.
Furue M; Kadono T
Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
[TBL] [Abstract][Full Text] [Related]
17. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?
Amagai M; Ahmed AR; Kitajima Y; Bystryn JC; Milner Y; Gniadecki R; Hertl M; Pincelli C; Kurzen H; Fridkis-Hareli M; Aoyama Y; Frusić-Zlotkin M; Müller E; David M; Mimouni D; Vind-Kezunovic D; Michel B; Mahoney M; Grando S
Exp Dermatol; 2006 Oct; 15(10):815-31. PubMed ID: 16984264
[TBL] [Abstract][Full Text] [Related]
18. Role of PKC and ERK Signaling in Epidermal Blistering and Desmosome Regulation in Pemphigus.
Egu DT; Kugelmann D; Waschke J
Front Immunol; 2019; 10():2883. PubMed ID: 31867019
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms Causing Acantholysis in Pemphigus-Lessons from Human Skin.
Egu DT; Schmitt T; Waschke J
Front Immunol; 2022; 13():884067. PubMed ID: 35720332
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
Gil MP; Modol T; España A; López-Zabalza MJ
Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
